Centrum 7/6  banner

January 10, 2022

You can read the full January 10 print issue of Chain Drug Review in its entirety here. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!

Retail Forecast 2022

Retail Forecast 2022

With the pandemic surging, pharmacy chains are planning for new solutions to fight the variants. At the same time retailers are looking to broaden affordable and accessible health care offerings when many people find such services from more traditional providers out of financial reach. Chains are also bolstering their e-commerce appeal to entice omnichannel shoppers.

Pharmacy Outlook: Peter Matz, FMI – The Food Industry Association

Pharmacy Outlook: Peter Matz, FMI – The Food Industry Association

Throughout the COVID-19 public health emergency, the importance of pharmacies to the health and well-being of the American public has never been more clear. Following the development and approval of COVID-19 vaccines early last year, pharmacies played an integral role in administering millions of vaccine doses to the American people to combat the spread of

Pharmacy Outlook: Scott Melville, CHPA

Pharmacy Outlook: Scott Melville, CHPA

One of the most enduring outcomes of the global pandemic is the tremendous acceleration of self-care as a cornerstone of health care. Now, more than ever, consumers are taking greater responsibility for, and control over, their own health care. While it’s exciting to see broad industry growth, there’s no denying that consumer demand, and the

Pharmacy Outlook: Chip Davis, HDA

Pharmacy Outlook: Chip Davis, HDA

From the White House to the kitchen table, supply chain disruptions have been on the minds of many Americans. But while the COVID-19 pandemic revealed the limits of operating within a global marketplace, the pharmaceutical supply chain was largely immune to bottlenecks. Consumer goods shortages have challenged us recently, yet pharmacies, health systems and physicians’

Pharmacy Outlook: Dan Leonard, AAM

Pharmacy Outlook: Dan Leonard, AAM

When patients receive their prescriptions at the pharmacy counter, the pharmacist is handing them a generic medicine nine times out of 10. Because of that, their co-pay is about 8.5 times more affordable than those for brands; 93% of the time generic co-pays are below $20. Doctors, pharmacists and patients count on the value proposition

Pharmacy Outlook: B. Douglas Hoey, NCPA

Pharmacy Outlook: B. Douglas Hoey, NCPA

One positive result of the coronavirus pandemic is that it has forever changed the consumer’s view of pharmacy. Of course, the evolving perception of the role of the pharmacist was already very much in progress. But the pandemic propelled it forward in ways that will have some radical effects on the business model of community

Pharmacy Outlook: Steve Anderson, NACDS

Pharmacy Outlook: Steve Anderson, NACDS

A January 2021 Bloomberg headline declared: “If They Nail Vaccinations, Drugstores Will Be the Heroes of 2021.” Indeed, NACDS members and their teams — in traditional drug stores, supermarkets and mass retail — are doing that and more. By staying open, filling gaps in care, rolling out COVID testing, and vaccinating against COVID, flu and

PP_1170x120_10-25-21